- Home
- JYD vs INM Comparison
JYD vs INM Comparison
Compare JYD & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.93
HOLD
Current Price
$1.43
Company Overview
Basic Information| Metric | JYD | INM |
|---|---|---|
| Founded | 2001 | 1981 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 7.7M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | JYD | INM |
|---|---|---|
| Price | $0.93 | $1.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 105.0K | 89.0K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.12 | $0.58 |
| 52 Week High | $6.85 | $2.50 |
Technical Indicators
Market Signals| Indicator | JYD | INM |
|---|---|---|
| Relative Strength Index (RSI) | 48.71 | 44.54 |
| Support Level | $0.66 | $1.42 |
| Resistance Level | $1.07 | $1.52 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 15.05 | 26.67 |
Price Performance
Historical Comparison JYD
INM
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, fragmented logistics, and chartered airline freight services, supply chain management, and other value-added services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.